Search

Your search keyword '"Struelens M"' showing total 676 results
Start Over Author "Struelens M"

Refine your results

more »

more »

more »

more »

more »
676 results on '"Struelens M"'

86. Abstracts

Author

Axon, A. T. R., Donnaym, Debongnej C, Tytgat, G. N. J., Bartelsman, J. F. W. M., René, E., Verdon, R., Rozé, C., Vallot, T., Matheron, S., Leport, C., Marche, C., Van Laethem, Y., Hermans, P., Clumeck, N., Van Laethem, J. L., Bourgeois, N., Gelin, M., Jacobs, F., Rickaert, F., Van De Stadt, J., Van Gossum, A., Vereerstraeten, P., Adler, M., McDonald, G. B., Silverstein, Fred, Berg, N. G., Delmotte, Ph., Petermans, J., Mutsers, A., Degrez Th., de Halleux J., Debongnie J. C., Fiasse R., Mainguet P., Thirapathi, Y., Korwin, J. D. de, Blech, M. F., Rossit, C., Conroy, M. C., Hartemann, P., Burdin, J. C., Schmitt, J., Van Avermaet, S., Debeuckelaere, S., Du Ville, L., Potvin, P., Devis, G., Urbain, D., Jeanmart, J., Lemone, M., Kiromera, A., Van Daele, D., Saikali, S., De Wit, S., Thys, O., Hoang, P., Jewell, D. P., Vandelli, A., Cariani, G., Bonora, G., Lenzi, T., Fontana, G., Wandall, J. H., Alnor-Hansen, D., Hage, E., Garcéa Reinoso C., Saez-Royuela F., Fernandez Guerrero M., Porres Cubero JC., González Campos C., Spiessens, C., Witte, P. de, Geboes, K., Lemli, J., de Baets, M. H., Cook, G. C., Debongne, J. C., Jouret, A., Haot, J., Russo, A., Aprile, G., Magnano, A., Delmée, M., ctors, N., De Vos, R., eboes, K., utgeerts, P., esmet, V., antrappen, G., Motte, S., Dumonceau, J. M., Deviere, J., Baize, M., Thys, J. P., Serruys, E., Cremer, M., De Koster, E, Nyst, JF, Glupczynski, Y, Deprez, C, Deltenre, M, Bechi, P., Dei, R., Amorosi, A., Pantalone, D., Pucciani, F., Napoli, A. Di, Petrino, R., Boero, M., Morgando, A., Piglia, R., Chiandussi, L., Bologna, E., Stroppiana, M., Peyre, S., Rizzi, R., Bangera, M., Sateqna-Buidetti, C., Ramdani, B., Lamy, V., Famerée, D., Cappelli, J., Moisse, R., de Korwin, J. D., Gobert, B., Bene, M. C., Conroy, M. C., Schmitt, J., Burdin, J. C., Faure, G., Benhamou, JP, De Koster, E, Nyst, JF, Deltenre, M, Wyatt, J I, Méqraud, F., Brassens-Rabbé, M. P., Albenque, M., Nejjari, C., Rathbone, B. J., Gasbarrini, G., Pretolani, S., Careddu, N., Cilia, D., Acampora, P., Brocchi, E., Bonvicini, F., Malfertheiner, P., Geboes, K., Ectors, N., Scarpignato, Carmelo, Deltenre M., Glupczynski Y., De Koster E., Nyst JF., Otero J., Dondelinger, R. F., Kurdziel, J. C., Goffette, P., Kurdziel, J. C., Dardenne, A. N., Pringot, J., Dondelinger, R. F., Van Gansbeke, P., Lalmand, B., Grassart, A., Gelin, M., Struyven, J., Valette, PJ, Brandtzaeg, P., Halstensen, T. S., Helgeland, L., Kett, K., Cuvelier, C., Jewell, P. P., van Deventer, Sander J. H., Radema, Sandra A., Tytgat, Guido N. J., de Reuck, M., Potvliege, R., Burette, A., Glupczynski, Y., Deprez, C., Glupczynski, Y., Van Den Borre, C., Goossens, H., Verhas, M., Bourdeaux, L., DeVos, D., Devreker, T., Glupczynski, Y., Goutier, S., Cpttone, C., Disclafani, G., Genova, G., Romeo, S., Bazan, P., Garcéa Reinoso C, Saez-Royuela F, González Campos C, Struelens, M. J., Nonhoff, C., Maas, A., Rost, F., Serruys, E., Adler, M., Delmée, M., Gay, G., and Delmotte, S.

Published
1990
Full Text
View/download PDF

99. Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013

Author

Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C. S., Struelens, M. J., Robo, A., Hatibi, I. H., Alis, J. C., Sargsyan, S., Gurbanov, S., Gribkova, N., Ranst, M., Ieven, G., Patteet, S., Tomic, S., Korsun, N., Drazenovic, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., Sylvie van der WERF, Manuguerra, J. -C, Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, A., Mentis, A. F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M. R., Landini, M. P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, K., Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S. G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, E., Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, J., Staroňová, E., Županc, T. A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, I., Bermingham, A., Rakhimov, R., Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), European Centre for Disease Prevention and Control [Stockholm, Sweden] (ECDC), Experts of the MERS-CoV Working Group Members of this working group who provided survey data: Albania: Alma Robo, Iris Hasibra (Hatibi), Institute of Public Health, Tirana Andorra: Josep Casals Alis, Ministry of Health, Welfare and Labour, Andorra la Vella Armenia: Shushan Sargsyan, Virology Laboratory, Centre for Diseases Control and Prevention, Yerevan Austria: Stephan Aberle, Department of Virology, Medical University of Vienna, Vienna Azerbaijan: Sadraddin Gurbanov, National Virology Laboratory, National Anti-Plague Station, Baku Belarus: Natalia Gribkova, Laboratory for Influenza and Influenza-like Diseases, Republican Research and Practical Center for Epidemiology and Microbiology, Minsk Belgium: Marc Van Ranst, Greet Ieven and Sophie Patteet, National Reference Centre of Respiratory Viruses, University Hospital Leuven and UZA Antwerpen, Antwerpen Bosnia and Herzegovina: Stanka Tomic, Microbiology Department, Institute of Public Health of the Republic of Srpska, Banja Luka Bulgaria: Neli Korsun, National Laboratory 'Influenza and ARD', Department of Virology, National Centre of Infectious and Parasitic Diseases, Sofia Croatia: Vladimir Drazenovic, National Influenza Centre, Croatian National Institute of Public Health, Zagreb Cyprus: Despo Pieridou-Bagkatzouni, Microbiology Department, Nicosia General Hospital, Nicosia Czech Republic: Helena Jirincova, Martina Havlickova, National Reference Laboratory for Influenza, National Institute for Public Health, Prague Denmark: Anders Fomsgaard, Virus Research and Development Laboratory, Department Microbiology Diagnostic and Virology, Statens Serum Institut, Copenhagen Estonia: Külli Rae, Laboratory of Communicable Diseases, Health Board, Tallinn Finland: Maija Lappalainen, Department of Virology and Immunology, Helsinki University Hospital, Laboratory Services (HUSLAB) and Niina Ikonen, Virology Unit, National Institute for Health and Welfare, Helsinki France: Bruno Lina, Centre National de Référence des Virus Influenza – HCL, Lyon and Sylvie van der Werf, Unit of Molecular Genetics of RNA viruses, Institut Pasteur and Jean-Claude Manuguerra, Cellule d’Intervention Biologique d’Urgence (CIBU), Institut Pasteur, Paris Georgia: Ann Machablishvili, National Influenza Centre, National Centre for Disease Control and Public Health, Tbilisi Germany: Markus Eickmann, Institut für Virologie der Philipps-Universität in Marburg and Thorsten Wolff, Div of Influenza and other Respiratory viruses, Robert Koch-Institut, and Dr. Gerhard Dobler, Bundeswehr Instittue of Microbiology, and Jonas Schmidt-Chanasit, WHOCC for Arbovirus and Haemorrhagic Fever Reference and Research at Bernhard Nocht Institute for Tropical Medicine, Hamburg, and Christian Drosten, Virology Institute, Bonn Greece: Anna Papa, National Reference Laboratory for Arboviruses and Hemorrhagic Fever viruses, Aristotle University of Thessaloniki, Thessaloniki and Andreas F. Mentis, National Influenza Reference Laboratory of Southern Greece/Hellenic Pasteur Institute, Athens Hungary: Zoltan Kis, Department for Respiratory Viruses / National Biosafety Laboratory, B. Johan National Center for Epidemiology, Budapest Iceland: Arthur Löve, Department of Virology, Landspitali- National University Hospital, Reykjavik Ireland: Suzie Coughlan, National Virus Reference Laboratory/University College Dublin, Dublin Israel: Michal Mandelboim, Central Virology Laboratory, Sheba Medical Center, Tel Hashomer Italy: Maria R. Capobianchi, Laboratory of Virology/National Institute for Infectious Diseases Lazzaro Spallanzani, and Maria Paola Landini, Regional Center for Emerging Infections (CRREM)/ Unit of Clinical Microbiology, St. Orsola General Hospital, Bologna, and Fausto Baldanti, Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, and Giorgio Palu, Microbiology and Virology/Padova University Hospital, and Valeria Ghisetti, Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, Torino, and Isabella Donatelli, National Influenza Centre, Instituto Superiore di Sanita, Kazakhstan: Gaukhar Nusupbayeva, Zarina Tokhtabakiyeva, National Reference Laboratory on Control of Viral Infections, Scientifical-Practical Center of Sanitary and Epidemiological Expertise and Monitoring, Almaty Kyrgyzstan: Kaliya Kasymbekova, Centre of Molecular-Genetic and Microbiological Investigations, Department of State Sanitary Epidemiological Surveillance, Bishkek Latvia: Jelena Storozenko, Riga East University Hospital, Latvian Centre of Infectious Diseases, National Microbiology Reference Laboratory, Riga Liechtenstein: Sabine Erne, Office of Public Health, Country Administration of Principality of Liechtenstein Lithuania: Algirdas Griskevicius, National Public Health Surveillance Laboratory, Vilnius Luxembourg: Matthias Opp, Laboratoire National de Santé, Luxembourg Malta: Christopher Barbara, Pathology Department, Mater Dei Hospital, Msida Montenegro: Zoran Vratnica, Centre for Medical Microbiology, Public Health Institute of Montenegro, Podgorica Netherlands: Chantal Reusken, Centre for Infectious Disease Research, Diagnostics and Screening, National Institute for Public Health and the Environment, Bilthoven Norway: Susanne Gjeruldsen Dudman and Olav Hungnes, Department of Virology, Norwegian Institute of Public Health, Oslo Poland: Katarzyna Pancer, National Institute of Public Health- National Institute of Hygiene, Department of Virology, Warsaw Portugal: Raquel Guiomar, National Influenza Reference Laboratory, Infectious Diseases Department, National Institute of Health, Lisboa Republic of Moldova: Veronica Eder, Laboratory of Viral Respiratory Infections, National Center for Public Health, Chisinau Romania: Emilia Lupulescu, Laboratory for Respiratory Viruses/ NIRDMI Cantacuzino, Bucharest Russian Federation: Svetlana Yatsyshina, Reference Centre for Infection Agents, Central Research Institute of Epidemiology (CRIE), Rospotrebnadzor, Moscow, and Maria Pisareva and Zhanna Buzitskaya, Laboratory of Molecular Virology and Genetic Engineering, Research Institute of Influenza, St Petersburg, and Alexander Sergeev, State Research Center of Virology and Biotechnology VECTOR, Novosibirsk Serbia: Jasminka Nedeljković, Respiratory Department, Torlak Institute of Immunology and Virology, Belgrade Slovakia: Edita Staroňová, National Influenza Center/Public Health Authority, Bratislava Slovenia: Tatjana Avšič Županc, Miroslav Petrovec, Miša Korva, University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, and Katarina Prosenc, Laboratory for Virology, National Public Health Institute Slovenia, Ljubljana Spain: Inmaculada Casas, Influenza National Reference Laboratory, National Influenza Center-Madrid, Instituto de Salud Carlos III, Majadahonda, Madrid and Ramon Cisterna Clinical microbiology and infection control, Hospital Basurto Bilbao Spain Sweden: Hans Gaines, Swedish Institute for Communicable Disease Control, Stockholm Switzerland: Pascal Cherpillod, National Reference Centre for Emerging Viral Infections, Laboratory of Virology, Division of Infectious Diseases University of Geneva Hospitals, Geneva Tajikistan: Niginamo Zakirova, Virology Laboratory, State Sanitary-Epidemiological Surveillance, Dushanbe The former Yugoslav Republic of Macedonia: Golubinka Bosevska, Laboratory for Virology and Molecular Diagnostics, Institute of Public Health, Skopje Turkey: Basak Altas, National Influenza Centre, Virology Reference and Research Laboratory, Public Health Institutions of Turkey, Ankara, and Meral Ciblak, National Influenza Reference Laboratory, Faculty of Medicine, University of Istanbul, Istanbul Turkmenistan: Central Reference Laboratory, Sanitary Epidemiologic Service, Ashgabat Ukraine: Alla Mironenko, National Influenza Centre, L.V.Gromashevsky Institute of Epidemiology & Infectious diseases NAMS, and Tetiana Dykhanovska and Iryna Demchyshyna, Centre of influenza and ARVI, Central Sanitary and Epidemiological Station, Kiev United Kingdom: Alison Bermingham, Respiratory Virus Unit, Virus Reference Department, Public Health England, London Uzbekistan: Ravshan Rakhimov, National Influenza Centre, Institute of Virology, Tashkent., and We thank the ECDC National Microbiology Focal Points in EU/EEA countries, focal points from laboratories of the EuroFlu and ENIVD networks for coordinating data collection and for dedicated and rapid responses to the surveys.

Subjects
Epidemiology, Middle East respiratory syndrome coronavirus, [SDV]Life Sciences [q-bio], SARS (Disease), MERS (Disease), medicine.disease_cause, World Health Organization, Communicable Diseases, Emerging, World health, Viral genetics, Coronavirus infections -- Laboratory manuals, Environmental protection, Virology, Environmental health, medicine, media_common.cataloged_instance, Humans, European Union, European union, Coronavirus, media_common, Middle East, business.industry, Reverse Transcriptase Polymerase Chain Reaction, Public Health, Environmental and Occupational Health, Reference Standards, European region, Health Surveys, Diseases -- Causes and theories of causation, Middle East Respiratory Syndrome Coronavirus, RNA, Viral, Disease prevention, business, Coronavirus Infections, Laboratories, Sentinel Surveillance, Sequence Analysis
Abstract

Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region., peer-reviewed

Published
2014
Full Text
View/download PDF

100. Laboratory preparedeness for detection and monitoring of Shiga toxin-2producing Escherichia coli O104:H4 in Europe and response to the 2011 outbreak

Author

Rosin, P., Niskanen, T., Palmer, D., Struelens, M., Takkinen, M., DEnis Piérard, and Immunology and Microbiology

Subjects
E.coli
Abstract

A hybrid strain of enteroaggregative and Shiga toxin 2-producing Escherichia coli (EAEC-STEC) serotype O104:H4 strain caused a large outbreak of haemolytic uraemic syndrome and bloody diarrhoea in 2011 in Europe. Two surveys were performed in the European Union (EU) and European Economic Area (EEA) countries to assess their laboratory capabilities to detect and characterise this previously uncommon STEC strain. Prior to the outbreak, 11 of the 32 countries in this survey had capacity at national reference laboratory (NRL) level for epidemic case confirmation according to the EU definition. During the outbreak, at primary diagnostic level, nine countries reported that clinical microbiology laboratories routinely used Shiga toxin detection assays suitable for diagnosis of infections with EAEC-STEC O104:H4, while 14 countries had NRL capacity to confirm epidemic cases. Six months after the outbreak, 22 countries reported NRL capacity to confirm such cases following initiatives taken by NRLs and the European Centre for Disease Prevention and Control (ECDC) Food- and Waterborne Disease and Zoonoses laboratory network. These data highlight the challenge of detection and confirmation of epidemic infections caused by atypical STEC strains and the benefits of coordinated EU laboratory networks to strengthen capabilities in response to a major outbreak.

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results